HOME › DRUGS › RITONAVIR
ACTIVE SUBSTANCE / INN

RITONAVIR

Brand name(s): LOPINAVIR AND RITONAVIR, Norvir, LOPINAVIR; RITONAVIR, RITONAVIR, TECHNIVIE, ATAZANAVIR SULFATE; RITONAVIR, ATAZANAVIR SULFATE AND RITONAVIR, VIEKIRA XR, Ritonavir Viatris (previously Ritonavir Mylan), NORVIR
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA204587
HIV Infections
ACTIVE SUBSTANCE
Ritonavir
REGULATORS
FDA · EMA
SPONSORS / MAH
MYLAN PHARMA, ABBVIE, EMCURE PHARMS LTD
TOTAL APPLICATIONS
12
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LOPINAVIR; RITONAVIRANDA091202MYLAN PHARMANone (Tentative Approval)
RITONAVIRANDA204587HETERO LABS LTD IIIPrescription
RITONAVIRNDA205040CIPLA LIMITEDNone (Tentative Approval)
VIEKIRA XRNDA208624ABBVIEDiscontinued
ATAZANAVIR SULFATE AND RITONAVIRNDA022282MATRIX LABS LTDNone (Tentative Approval)
LOPINAVIR AND RITONAVIRANDA204739MACLEODS PHARMS LTDPrescription
TECHNIVIENDA207931ABBVIEDiscontinued
ATAZANAVIR SULFATE; RITONAVIRNDA205508EMCURE PHARMS LTDNone (Tentative Approval)
NORVIRNDA020680ABBOTTDiscontinued
NORVIRNDA022417ABBVIEPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NorvirAbbVie Deutschland GmbH & Co. KGAuthorised25/08/1996HIV Infections
Ritonavir Viatris (previously Ritonavir Mylan)Viatris LimitedAuthorised09/11/2017HIV Infections

FULL INTELLIGENCE ON RITONAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →